Featured Research

from universities, journals, and other organizations

Early-stage Lung Cancer Identified Using Computer-aided System

Date:
April 26, 2009
Source:
American Roentgen Ray Society
Summary:
A computer-aided detection method may help radiologists identify cancerous lung nodules at an early stage, according to a study performed at the University of Maryland Medical Center in Baltimore, Md.

A computer-aided detection (CAD) method may help radiologists identify cancerous lung nodules at an early stage, according to a study performed at the University of Maryland Medical Center in Baltimore, MD.

“In our study we identified 88 nodules that were not detected at the time of interpretation but visible in retrospect and were subsequently determined to be lung cancers,” said Joseph Jen-Sho Chen, MD, lead author of the study. “CAD was applied to the overlooked nodules and we found that 45-55% of the missed nodules were found using the CAD software. The implication of our study is that it is possible that at least some of the nodules representing lung cancer might have been diagnosed at an earlier stage, resulting in early treatment and perhaps a better outcome,” said Dr. Chen.

“The complexity of the structures in the chest including the ribs, mediastinum and pulmonary vessels can make it difficult to identify separate pulmonary nodules that may represent an early lung cancer from normal anatomy,” said Dr. Chen. “Computer-aided detection is a method that can be used to assist the radiologist in the search for lung cancer. The software highlights abnormalities that may be overlooked by the radiologist on an initial search,” said Dr. Chen.

“Lung cancer accounts for more than 150,000 deaths annually in the US alone. Overall, only about 15% of patients survive five years or more, but with early detection, survival increases to greater than 70%,” said Dr. Chen. “The use of CAD may be particularly valuable in early lung cancer, where the findings are often subtle,” he said.

“We hope ultimately that studies such as ours will determine whether CAD should be adopted as part of the standard armamentarium for evaluating lung nodules,” said Dr. Chen.

This study will be presented at the 2009 ARRS Annual Meeting in Boston, MA, on Tuesday, April 28.


Story Source:

The above story is based on materials provided by American Roentgen Ray Society. Note: Materials may be edited for content and length.


Cite This Page:

American Roentgen Ray Society. "Early-stage Lung Cancer Identified Using Computer-aided System." ScienceDaily. ScienceDaily, 26 April 2009. <www.sciencedaily.com/releases/2009/04/090423132652.htm>.
American Roentgen Ray Society. (2009, April 26). Early-stage Lung Cancer Identified Using Computer-aided System. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2009/04/090423132652.htm
American Roentgen Ray Society. "Early-stage Lung Cancer Identified Using Computer-aided System." ScienceDaily. www.sciencedaily.com/releases/2009/04/090423132652.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins